home / stock / imgn / imgn articles

IMGN Articles, ImmunoGen Inc.

Stock Information
Company Name: ImmunoGen Inc.
Stock Symbol: IMGN
Market: NASDAQ
Website: immunogen.com
Menu
IMGN IMGN Quote IMGN Short IMGN News IMGN Articles IMGN Message Board
Get IMGN Alerts

News, Short Squeeze, Breakout and More Instantly...
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall | Benzinga

Friday, AbbVie Inc (NYSE:ABBV) reported fourth-quarter adjusted EPS of $2.79, down 22.5% Y/Y, beating the consensus of $2.77. Fourth...
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures | Benzinga

William Blair has upgraded AbbVie Inc (NYSE:ABBV), noting confidence in the company’s growth outlook over the near and long te...

Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Realty Income (NYSE: O) and recommends staying with it. "It&r...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGN, HA, CERE, HOLI | Benzinga

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 | Benzinga

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, BVH, IMGN | Benzinga

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGN, HA, EAR | Benzinga

NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal | Benzinga

SystImmune and Bristol Myers Squibb & Co (NYSE: BMY) announced an exclusive license and collaboration agreement for Sy...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HA, PFIN, IMGN, SP | Benzinga

NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...

AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals | Benzinga

Wednesday, AbbVie Inc (NYSE: ABBV) agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for a total equity value ...
Next 10